Make sure your chart accurately reflects all weight-related health conditions
SUSTAIN Trials The SUSTAIN clinical trial program evaluated the safety and efficacy of semaglutide in the treatment of type 2 diabetes
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines variants in the GLP1R gene (rs6923761) and related metabolic pathways that may help provide context for why some individuals experience stronger appetite suppression earlier, while others require higher doses for similar effect
The GLP1 Success Program is designed for people who are already taking GLP1 medications (such as Wegovy or Zepbound) through another provider and want expert nutritional and lifestyle support tailored to their needs
Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
Specifically, semaglutides directly activate GLP-1 receptors in neurons involved in appetite in the hypothalamus and the hindbrain